Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD" Results 61 - 80 of 260
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jun 2015, 11:04 am by Robert Reznick
District Court for the Eastern District of Pennsylvania approved a consent order (the “Consent Order”) between the Federal Trade Commission and defendants Cephalon, Inc. and its parent, Teva Pharmaceutical Industries Ltd.,[1] resolved long-running antitrust litigation stemming from four “reverse payment” settlements of Hatch-Waxman patent infringement cases involving the branded drug Provigil®. [read post]
16 Jun 2015, 6:00 am
Teva Pharmaceutical Industries, Ltd. will make a total of $1.2B available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon’s illegal conduct. [read post]
25 May 2015, 4:15 am
  The parties have been back in court to fight over other patents, resulting in the decision Synthon B.V. v Teva Pharmaceutical Industries Ltd [2015] EWHC 1395 (Pat), which came out last week and which Darren reports in timely fashion.* When functionality cuts deep, it can be hard to handle: Yoshida appeal dismissedValentina's back again to pen on General Court's decision in Joined Cases C‑337/12 P to… [read post]
21 May 2015, 10:39 am
 The parties have been back in court to fight over other patents, resulting in the decision Synthon B.V. v Teva Pharmaceutical Industries Ltd [2015] EWHC 1395 (Pat), which came out this morning.The patents concerned are EP (UK) 2 177 528 and EP (UK) 2 361 924, both divisionals of EP (UK) 1 799 703, which was revoked by the EPO in opposition proceedings pursuant to Teva's withdrawal of it after a negative preliminary opinion. [read post]
14 May 2015, 4:00 am by Paula Bremner
Mylan Pharmaceuticals ULC, 2015 FC 17[7] [tadalafil Notice of Compliance case (“NOC”)], Justice de Montigny accepted that Eli Lilly’s patent for the new use of a drug to treat erectile dysfunction (“ED”) only promised ED treatment. [read post]
13 May 2015, 7:41 am by Lawrence B. Ebert
It would be no exaggeration to say that the discovery has even affected the Israeli economy.Teva Pharmaceutical Industries Ltd. [read post]
11 May 2015, 3:05 pm
.* A Kat visits #INTA15: Monday's mewsingsAfter an exciting lunch event subtitled "Sex, Drugs, and Motorcycle Clubs: Trademark Issues on the Edge", with speakers advertised as representing the cannabis industry, brands relating to adult content and the Hell's Angels, Jeremy attended a session where various academic papers were presented and debated. [read post]
23 Feb 2015, 2:55 am
*****  PREVIOUSLY, ON NEVER TOO LATE Never too late 33 [week ending Sunday 15 February] –- Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH  | The Logic of Innovation: Intellectual Property, and What the User Found There… [read post]
16 Feb 2015, 1:44 am
  * "Fool's errand": no need to create your own brand if you can use someone else's Jeremy notes Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH [2015] EWCA Civ 54 [on which see earlier katpost here], a trade mark infringement decision of the Court of Appeal, England and Wales, on parallel importation and over-stickering of pharmaceutical products. [read post]
2 Feb 2015, 2:20 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) reports on the Hague Court of Appeal’s summary ruling in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
20 Jan 2015, 4:23 pm by Richard M.
Supreme Court early this week overturned a Court of Appeals ruling that invalidated a patent by Teva Pharmaceutical Industries Ltd. on a multi-sclerosis drug (Copaxone), offering the drug manufacturer a chance to stall generic competitors. [read post]
20 Jan 2015, 8:40 am by Associated Press
Overturning the Federal Circuit, the Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug Copaxone. [read post]
27 Oct 2014, 5:27 am
The claimants were record companies claiming on their own behalf and in a representative capacity on behalf of the members of BPI (British Recorded Music Industry) and PPL (Phonographic Performance Ltd). [read post]
15 Oct 2014, 2:49 pm by Bloomberg
Teva Pharmaceutical Industries Ltd. got a mixed reception at a U.S. [read post]
13 Oct 2014, 8:46 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:14-cv-00167; filed October 7, 2014 in the Northern District of West Virginia • Plaintiffs: Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Teva Neuroscience, Inc.; Yeda Research and Development Co., Ltd. [read post]
13 Oct 2014, 9:01 am by Lyle Denniston
  The company has a reputation in the industry of moving aggressively to protect its monopoly advantage, even suing the FDA at one point — unsuccessfully. [read post]
27 Sep 2014, 1:29 am by Jon Gelman
” So says the website designed to market the drug known as Nuvigil, sold by Cephalon, a subsidiary of Teva Pharmaceutical Industries, Ltd. [read post]
8 Sep 2014, 4:55 am
According to the publisher Edward Elgar, the book “illustrates the crucial role that patent strategies play within processes of pharmaceutical innovation”  by “drawing on extensive country and company case studies” from the United States, Japan, South Korea and Israel and identifying “the key issues relevant to the revival of local pharmaceutical industries”. [read post]